PEOLA, SILVIA
PEOLA, SILVIA
SCIENZE MEDICHE
Accelerated activity of the mevalonate pathway supports the immune escape and multidrug-resistance phenotype of IGHV unmutated chronic lymphocytic leukemia cells
2011-01-01 M Coscia; M Rigoni; C Riganti; I Campia; C Vitale; V Griggio; S Peola; B Castella; F Pantaleoni; P Sciancalepore; D Drandi; P Omedè; M Ladetto; A Bosia; M Boccadoro; M Massaia
CD157 reduces acutemyeloid leukemia cell sensitivity tocytarabine through upregulation of MCL-1 anti-apoptotic protein
2019-01-01 Yuliya Yakymiv, Stefania Augeri, Giulia Fissolo, Cristiano Bracci, Silvia Peola, Stefano D’Ardia, Sembra Aydin, Massimo Massaia, Erika Ortolan, Ada Funaro.
CD157 REGULATES THE SENSITIVITY OF ACUTE MYELOID LEUKEMIA CELLS TO CHEMOTHERAPY BY MODULATING THE APOPTOTIC RESPONSE
2019-01-01 Yuliya Yakymiv, Stefania Augeri, Giulia Fissolo, Cristiano Bracci, Silvia Peola, Stefano D’Ardia, Semra Aydin, Massimo Massaia, Erika Ortolan, Ada Funaro.
Differential Effects of Microenvironmental Elements On Tumor Cells Survival in Chronic Lymphocytic Leukemia Patient Subsets with Good or Poor Prognosis
2009-01-01 Marta Coscia; Francesca Pantaleoni; Chiara Riganti; Micol Rigoni; Candida Vitale; Silvia Peola; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia
Distribution of γδ T cells in patients with hematological malignancies
2006-01-01 Mariani, S; Pantaleoni, F.; Peola, S.; Hwang, S.Y.; Castella, B.; Matta, G.; Foglietta, M.; Fiore, F.; Coscia, M.A.; Boccadoro, M.; Massaia, M.
Identification by serological proteome analysis (SERPA) of novel tumor associated antigens in chronic lymphocytic leukemia (CLL)
2011-01-01 M Coscia; V Griggio; M Capello; C Vitale; F Linty; S Peola; P Cappello; B Castella; M Rigoni; P Sciancalepore; D Drandi; M Ruggeri; P Omedè; M Ladetto; F Novelli; M Boccadoro; M Massaia
IDENTIFICATION BY SEROLOGICAL PROTEOME ANALYSIS (SERPA) OF TUMOR-ASSOCIATED ANTIGENS ELICITING ANTIBODY RESPONSES IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
2010-01-01 Marta Coscia; Michela Capello; Valentina Griggio; Federica Linty; Candida Vitale; Silvia Peola; Barbara Castella; Micol Rigoni; Daniela Drandi; Marina Ruggeri; Paola Omedè; Marco Ladetto; Franco Novelli; Mario Boccadoro; Massimo Massaia
Identification by serological proteome analysis (SERPA) of tumor-associated antigens eliciting antibody-responses in chronic lymphocytic leukemia
2011-01-01 Griggio V; Capello M; Linty F; Vitale C; Peola S; Cappello P; Castella B; Rigoni M; Sciancalepore P; Drandi D; Ruggeri M; Omedè P; Ladetto M; Novelli F; Boccadoro M; Massaia M; Coscia M
IGHV Unmutated Chronic Lymphocytic Leukemia (CLL) B Cells Are More Susceptible to Spontaneous Apoptosis Than Mutated CLL B Cells and Are Subject to the Anti-Apoptotic Effect of Environmental Signals
2010-01-01 Marta Coscia; Francesca Pantaleoni; Chiara Riganti; Candida Vitale; Micol Rigoni; Silvia Peola; Daniela Drandi; Barbara Castella; Marina Ruggeri; Paola Omedè; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia
IGHV UNMUTATED CLL B CELLS ARE MORE PRONE TO SPONTANEOUS APOPTOSIS AND DEPEND FROM THE ANTI-APOPTOTIC EFFECT OF ENVIRONMENTAL SIGNALS
2011-01-01 Marta Coscia; Francesca Pantaleoni; Chiara Riganti; Candida Vitale; Micol Rigoni; Silvia Peola; Daniela Drandi; Marco Ladetto; Marina Ruggeri; Valentina Griggio; Barbara Castella; Patrizia Sciancalepore; Paola Omedè; Amalia Bosia; Mario Boccadoro; Massimo Massaia
Immunoglobulin variable heavy-chain (Ig Vh) mutational status and tumor microenvironment interactions in B-cell chronic lymphocytic leukaemia
2007-01-01 Pantaleoni F; Coscia M; Bussolati B; Deambrosis I; Peola S; Rigoni M; Boccadoro M; Camussi G; Massaia M
IMPACT OF THE MEVALONATE PATHWAY AND HIF/PGP AXIS IN MODULATING MULTIDRUG-RESISTANCE IN UNMUTATED CLL CELLS
2011-01-01 Marta Coscia; Micol Rigoni; Chiara Riganti; Ivana Campia; Candida Vitale; Silvia Peola; Barbara Castella; Valentina Griggio; Francesca Pantaleoni; Patrizia Sciancalepore; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia
MYELOMA CELLS DRIVE THE MATURATION OF DENDRITIC CELLS VERSUS A TH2-PROMOTING PHENOTYPE WHICH IMPAIRS T-CELL ACTIVATION
2004-01-01 Fiore F; Nushack B; Peola S; Coscia M; Foglietta M; Canavese M; Mariani S; Muraro M; Bruno B; Boccadoro M; Massimo M
Myeloma cells drive the maturation of dendritic cells versus a Th2-promoting phenotype which impairs T-cell activation.
2003-01-01 Fiore F; Nushack B; Peola S; Coscia M; Folgietta M; Canavese M; Mariani S; Muraro M; Bruno B; Boccadoro M; Massaia M
PHENOTYPIC AND FUNCTIONAL FEATURES OF VGAMMA9/VDELTA2 T CELLS CORRELATE WITH THE MUTATIONAL STATUS OF THE TUMOR IMMUNOGLOBULINE AND WITH DISEASE AGGRESSIVENESS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2009-01-01 Coscia M.; Peola S.; Pantaleoni F.; Matta G.M.; Foglietta M.; Vitale C.; Angelini D.F.; Chiaretti S.; Riganti C.; Guarini A.; Drandi D.; Ladetto M.; Bosia A.; Foà R.; Battistini L.; Boccadoro M.; Fournie J.J.; Massaia M.
Phenotypic and Functional Features of V{gamma}9/V{delta}2 T Cells in Chronic Lymphocytic Leukemia Are Strongly Correlated with the Mutational Status of the Immunoglobulin Heavy Chain Variable Region (IgVH) and Metabolic Activity of the Mevalonate Pathway in Tumor Cells
2007-01-01 Marta Coscia; Silvia Peola; Giorgia Matta; Francesca Pantaleoni; Myriam Foglietta; Daniela Angelini; Sabina Chiaretti; Chiara Riganti; Anna Guarini; Daniela Drandi; Marco Ladetto; Amalia Bosia; Robin Foà; Luca Battistini; Mario Boccadoro; Jean Jacques Fournie; Massimo Massaia
ROLE OF THE MEVALONATE PATHWAY IN THE IMMUNOMODULATORY ACTIVITY OF ZOLEDRONIC ACID
2004-01-01 Pantaleoni F; Mariani S; Muraro M; Peola S; Nuschak B; Foglietta M; Castella B; Fiore F; Coscia M; Boccadoro M; Massaia M
SEROLOGICAL PROTEOME ANALYSIS (SERPA) FOR THE IDENTIFICATION OF TUMOR-ASSOCIATED ANTIGENS ELICITING ANTIBODY-RESPONSES IN CHRONIC LYMPHOCYTIC LEUKEMIA
2011-01-01 M. Coscia; V. Griggio; M. Capello; F. Linty; C. Vitale; S. Peola; P. Cappello; B. Castella; M. Rigoni; P. Sciancalepore; D. Drandi; M. Ruggeri; P. Omedè; M. Ladetto; F. Novelli; M. Boccadoro; M. Massaia
SEROLOGICAL PROTEOME ANALYSIS (SERPA) FOR THEIDENTIFICATION OF NOVEL TUMOR-ASSOCIATED ANTIGENS INCHRONIC LYMPHOCYTIC LEUKEMIA
2011-01-01 M. Coscia; V. Griggio; M. Capello; F. Linty; C. Vitale; S. Peola; B. Castella; M. Rigoni; D. Drandi; M. Ruggeri; P. Omede`; M. Ladetto; F. Novelli; M. Boccadoro; M. Massaia
Targeting the mevalonate pathway and downstream signaling pathways as a strategy to circumvent multidrug-resistance in CLL cells
2011-01-01 Rigoni M; Coscia M; Riganti C; Campia I; Vitale C; Peola S; Castella B; Griggio V; Pantaleoni F; Sciancalepore P; Drandi D; Ladetto M; Bosia A; Boccadoro M; Massaia M
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Accelerated activity of the mevalonate pathway supports the immune escape and multidrug-resistance phenotype of IGHV unmutated chronic lymphocytic leukemia cells | 2011 | M Coscia; M Rigoni; C Riganti; I Campia; C Vitale; V Griggio; S Peola; B Castella; F Pantaleoni; P Sciancalepore; D Drandi; P Omedè; M Ladetto; A Bosia; M Boccadoro; M Massaia | |
| CD157 reduces acutemyeloid leukemia cell sensitivity tocytarabine through upregulation of MCL-1 anti-apoptotic protein | 2019 | Yuliya Yakymiv, Stefania Augeri, Giulia Fissolo, Cristiano Bracci, Silvia Peola, Stefano D’Ardia, Sembra Aydin, Massimo Massaia, Erika Ortolan, Ada Funaro. | |
| CD157 REGULATES THE SENSITIVITY OF ACUTE MYELOID LEUKEMIA CELLS TO CHEMOTHERAPY BY MODULATING THE APOPTOTIC RESPONSE | 2019 | Yuliya Yakymiv, Stefania Augeri, Giulia Fissolo, Cristiano Bracci, Silvia Peola, Stefano D’Ardia, Semra Aydin, Massimo Massaia, Erika Ortolan, Ada Funaro. | |
| Differential Effects of Microenvironmental Elements On Tumor Cells Survival in Chronic Lymphocytic Leukemia Patient Subsets with Good or Poor Prognosis | 2009 | Marta Coscia; Francesca Pantaleoni; Chiara Riganti; Micol Rigoni; Candida Vitale; Silvia Peola; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia | |
| Distribution of γδ T cells in patients with hematological malignancies | 2006 | Mariani, S; Pantaleoni, F.; Peola, S.; Hwang, S.Y.; Castella, B.; Matta, G.; Foglietta, M.; Fiore, F.; Coscia, M.A.; Boccadoro, M.; Massaia, M. | |
| Identification by serological proteome analysis (SERPA) of novel tumor associated antigens in chronic lymphocytic leukemia (CLL) | 2011 | M Coscia; V Griggio; M Capello; C Vitale; F Linty; S Peola; P Cappello; B Castella; M Rigoni; P Sciancalepore; D Drandi; M Ruggeri; P Omedè; M Ladetto; F Novelli; M Boccadoro; M Massaia | |
| IDENTIFICATION BY SEROLOGICAL PROTEOME ANALYSIS (SERPA) OF TUMOR-ASSOCIATED ANTIGENS ELICITING ANTIBODY RESPONSES IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) | 2010 | Marta Coscia; Michela Capello; Valentina Griggio; Federica Linty; Candida Vitale; Silvia Peola; Barbara Castella; Micol Rigoni; Daniela Drandi; Marina Ruggeri; Paola Omedè; Marco Ladetto; Franco Novelli; Mario Boccadoro; Massimo Massaia | |
| Identification by serological proteome analysis (SERPA) of tumor-associated antigens eliciting antibody-responses in chronic lymphocytic leukemia | 2011 | Griggio V; Capello M; Linty F; Vitale C; Peola S; Cappello P; Castella B; Rigoni M; Sciancalepore P; Drandi D; Ruggeri M; Omedè P; Ladetto M; Novelli F; Boccadoro M; Massaia M; Coscia M | |
| IGHV Unmutated Chronic Lymphocytic Leukemia (CLL) B Cells Are More Susceptible to Spontaneous Apoptosis Than Mutated CLL B Cells and Are Subject to the Anti-Apoptotic Effect of Environmental Signals | 2010 | Marta Coscia; Francesca Pantaleoni; Chiara Riganti; Candida Vitale; Micol Rigoni; Silvia Peola; Daniela Drandi; Barbara Castella; Marina Ruggeri; Paola Omedè; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia | |
| IGHV UNMUTATED CLL B CELLS ARE MORE PRONE TO SPONTANEOUS APOPTOSIS AND DEPEND FROM THE ANTI-APOPTOTIC EFFECT OF ENVIRONMENTAL SIGNALS | 2011 | Marta Coscia; Francesca Pantaleoni; Chiara Riganti; Candida Vitale; Micol Rigoni; Silvia Peola; Daniela Drandi; Marco Ladetto; Marina Ruggeri; Valentina Griggio; Barbara Castella; Patrizia Sciancalepore; Paola Omedè; Amalia Bosia; Mario Boccadoro; Massimo Massaia | |
| Immunoglobulin variable heavy-chain (Ig Vh) mutational status and tumor microenvironment interactions in B-cell chronic lymphocytic leukaemia | 2007 | Pantaleoni F; Coscia M; Bussolati B; Deambrosis I; Peola S; Rigoni M; Boccadoro M; Camussi G; Massaia M | |
| IMPACT OF THE MEVALONATE PATHWAY AND HIF/PGP AXIS IN MODULATING MULTIDRUG-RESISTANCE IN UNMUTATED CLL CELLS | 2011 | Marta Coscia; Micol Rigoni; Chiara Riganti; Ivana Campia; Candida Vitale; Silvia Peola; Barbara Castella; Valentina Griggio; Francesca Pantaleoni; Patrizia Sciancalepore; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia | |
| MYELOMA CELLS DRIVE THE MATURATION OF DENDRITIC CELLS VERSUS A TH2-PROMOTING PHENOTYPE WHICH IMPAIRS T-CELL ACTIVATION | 2004 | Fiore F; Nushack B; Peola S; Coscia M; Foglietta M; Canavese M; Mariani S; Muraro M; Bruno B; Boccadoro M; Massimo M | |
| Myeloma cells drive the maturation of dendritic cells versus a Th2-promoting phenotype which impairs T-cell activation. | 2003 | Fiore F; Nushack B; Peola S; Coscia M; Folgietta M; Canavese M; Mariani S; Muraro M; Bruno B; Boccadoro M; Massaia M | |
| PHENOTYPIC AND FUNCTIONAL FEATURES OF VGAMMA9/VDELTA2 T CELLS CORRELATE WITH THE MUTATIONAL STATUS OF THE TUMOR IMMUNOGLOBULINE AND WITH DISEASE AGGRESSIVENESS IN CHRONIC LYMPHOCYTIC LEUKEMIA | 2009 | Coscia M.; Peola S.; Pantaleoni F.; Matta G.M.; Foglietta M.; Vitale C.; Angelini D.F.; Chiaretti S.; Riganti C.; Guarini A.; Drandi D.; Ladetto M.; Bosia A.; Foà R.; Battistini L.; Boccadoro M.; Fournie J.J.; Massaia M. | |
| Phenotypic and Functional Features of V{gamma}9/V{delta}2 T Cells in Chronic Lymphocytic Leukemia Are Strongly Correlated with the Mutational Status of the Immunoglobulin Heavy Chain Variable Region (IgVH) and Metabolic Activity of the Mevalonate Pathway in Tumor Cells | 2007 | Marta Coscia; Silvia Peola; Giorgia Matta; Francesca Pantaleoni; Myriam Foglietta; Daniela Angelini; Sabina Chiaretti; Chiara Riganti; Anna Guarini; Daniela Drandi; Marco Ladetto; Amalia Bosia; Robin Foà; Luca Battistini; Mario Boccadoro; Jean Jacques Fournie; Massimo Massaia | |
| ROLE OF THE MEVALONATE PATHWAY IN THE IMMUNOMODULATORY ACTIVITY OF ZOLEDRONIC ACID | 2004 | Pantaleoni F; Mariani S; Muraro M; Peola S; Nuschak B; Foglietta M; Castella B; Fiore F; Coscia M; Boccadoro M; Massaia M | |
| SEROLOGICAL PROTEOME ANALYSIS (SERPA) FOR THE IDENTIFICATION OF TUMOR-ASSOCIATED ANTIGENS ELICITING ANTIBODY-RESPONSES IN CHRONIC LYMPHOCYTIC LEUKEMIA | 2011 | M. Coscia; V. Griggio; M. Capello; F. Linty; C. Vitale; S. Peola; P. Cappello; B. Castella; M. Rigoni; P. Sciancalepore; D. Drandi; M. Ruggeri; P. Omedè; M. Ladetto; F. Novelli; M. Boccadoro; M. Massaia | |
| SEROLOGICAL PROTEOME ANALYSIS (SERPA) FOR THEIDENTIFICATION OF NOVEL TUMOR-ASSOCIATED ANTIGENS INCHRONIC LYMPHOCYTIC LEUKEMIA | 2011 | M. Coscia; V. Griggio; M. Capello; F. Linty; C. Vitale; S. Peola; B. Castella; M. Rigoni; D. Drandi; M. Ruggeri; P. Omede`; M. Ladetto; F. Novelli; M. Boccadoro; M. Massaia | |
| Targeting the mevalonate pathway and downstream signaling pathways as a strategy to circumvent multidrug-resistance in CLL cells | 2011 | Rigoni M; Coscia M; Riganti C; Campia I; Vitale C; Peola S; Castella B; Griggio V; Pantaleoni F; Sciancalepore P; Drandi D; Ladetto M; Bosia A; Boccadoro M; Massaia M |